Updated:
Majycc eSante Invest
Majycc Innovation Santé is a fund of UI Investissement that supports high-potential startups in innovative healthcare sectors. Its mission is to create value...
Majycc eSante Invest
Majycc Innovation Santé is a fund of UI Investissement that supports high-potential startups in innovative healthcare sectors. Its mission is to create value for tomorrow's healthcare by backing ambitious projects. It focuses on late-stage venture capital, specializing in Series A and B rounds in France and Europe. The fund was formed in 2022 from the combination of Majycc eSanté Invest and UI Investissement.
General information
Firm type
Private Equity Firm
Year founded
2018
Location
Region
Europe
Country
France
City
Paris
Corporate office
Paris, France
Principals
Pauline de Breteuil
Directrice associée
Tanguy Besson
Chargé d'affaires senior
Pauline de Breteuil
Associate director
Tanguy Besson
VC Investor
Sector focus
Frequently asked questions
Which sectors and geographies does Majycc eSante Invest focus on?
Majycc eSante Invest is exclusively focused on digital health — software and technology products that operate within regulated healthcare environments, including telemedicine, clinical workflow tools, and patient-data platforms. Geographically, the firm concentrates on France as its home market, with additional activity in Belgium, Switzerland, and francophone North Africa where shared language and similar regulatory frameworks apply.
Does Majycc eSante Invest operate as a venture capital fund or a holding company?
Majycc eSante Invest operates as a private equity firm making direct equity investments into portfolio companies, rather than as a fund-of-funds or a corporate venture arm. Its structure is that of a specialist early-stage investor deploying proprietary capital or managed commitments into a single-sector digital health portfolio.
What makes Majycc eSante Invest structurally distinct from other European early-stage funds?
The firm's structural differentiator is its exclusive concentration on digital health — it does not diversify across other technology verticals, life sciences, or generalist consumer tech. Most European early-stage funds spread bets across digital, deeptech, and biotech to manage binary regulatory risk; Majycc eSante instead bets that deep domain expertise in a single regulated vertical will produce better sourcing and underwriting outcomes.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: